The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be

Study Title
A Clinical Trial to Evaluate the Long-term Safety and Durability of Efficacy
of BI 3720931, an Inhaled Lentiviral Vector Gene Therapy, After Single Dose
Administration in a Previous Clinical Trial, in People With Cystic Fibrosis
Rolled-over From a Previous Clinical Trial With BI 3720931 (Lenticlair™-ON)
Study DrugBI 3720931
Type of Study DrugGenetic therapy
Study Phase1/2
Study SponsorBoehringer Ingelheim

Link in registry(ies)

https://clinicaltrials.gov/study/NCT06429176 
Participating ECFS-CTN sitesPlease contact ecfs-ctn@uzleuven.be for most recent sitelist
AgeAdult patients